Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy



Status:Completed
Conditions:Anxiety, Anxiety, Chronic Pain, Depression, Insomnia Sleep Studies, Other Indications, Blood Cancer, Psychiatric, Pulmonary
Therapuetic Areas:Musculoskeletal, Oncology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:Any
Updated:4/6/2019
Start Date:December 28, 2014
End Date:November 5, 2016

Use our guide to learn which trials are right for you!

The Effect of Aromatherapy on Insomnia and Other Common Cancer Patient Symptoms

This randomized clinical trial studies aromatherapy and essential oils in improving insomnia
and other symptoms in patients with newly diagnosed acute leukemia. Aromatherapy and
essential oils may help improve insomnia and other complications caused by chemotherapy.

PRIMARY OBJECTIVES:

I. Does the addition of aromatherapy by diffusion of essential oils improve insomnia in newly
diagnosed, hospitalized leukemia patients?

SECONDARY OBJECTIVES:

I. Does the addition of aromatherapy by diffusion of essential oils improve other common
symptoms in newly diagnosed, hospitalized leukemia patients, including pain, nausea, lack of
appetite, shortness of breath, depression, anxiety and wellbeing? II. Do newly diagnosed,
hospitalized leukemia patients find the use of aromatherapy for symptom management a positive
experience?

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP I: Patients select between 3 scented essential oils: peppermint, lavender, or chamomile
which is diffused in the hospital room from approximately 9 PM in the evening until morning
during week 1 and placebo intervention using rose water during week 2.

GROUP II: Patients undergo placebo intervention using rose water during week 1 and
aromatherapy and essential oils as in Group I during week 2.

Inclusion Criteria:

- Patients who are newly diagnosed with acute leukemia and hospitalized to receive their
initial 4 weeks of intensive induction chemotherapy for this disease

Exclusion Criteria:

- Asthma or other reactive airway disease

- Sleep apnea

- Planned less than two week hospitalization

- Change in pain medications/sleeping medications/anxiety medications/antiemetics during
the trial

- Patients who have not completed their initial steroids

- Patients who are confused and unable to give informed consent
We found this trial at
1
site
Columbus, Ohio 43210
Principal Investigator: Lisa Blackburn
Phone: 614-293-2598
?
mi
from
Columbus, OH
Click here to add this to my saved trials